fig10

Integrated multi-omics profiling of immune microenvironment and drug resistance signatures for precision prognosis in prostate cancer

Figure 10. Single-cell level validation of the model. (A) Heatmap of subgroup proportions. Colors represent proportions (scores); (B) Survival curves for high and low-proportion groups; (C) ROC curve for 1-year survival rate prediction; (D) ROC curve for 5-year survival rate prediction. ROC: Receiver operating characteristic.

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/